QCM
BNTX icon

QRG Capital Management’s BioNTech BNTX Stock Holding History

QRG Capital Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,963
Closed -$489K – 1081
2025
Q3 		$489K Buy
+4,963
New +$531K 0.01% 730
2025
Q2 		– Sell
-2,347
Closed -$214K – 1122
2025
Q1 		$214K Sell
2,347
-68
-3% -$7.61K ﹤0.01% 1005
2024
Q4 		$275K Buy
+2,415
New +$276K ﹤0.01% 935
2024
Q3 		– Sell
-8,581
Closed -$690K – 1090
2024
Q2 		$690K Sell
8,581
-8,150
-49% -$745K 0.01% 641
2024
Q1 		$1.54M Buy
16,731
+4,144
+33% +$397K 0.02% 463
2023
Q4 		$1.33M Buy
12,587
+4,466
+55% +$450K 0.02% 478
2023
Q3 		$882K Buy
+8,121
New +$898K 0.02% 515

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

QRG Capital Management's BNTX Position: Q4 2025 in Review

QRG Capital Management sold out of BioNTech (BNTX) in Q4 2025, closing a stake of 4,963 shares — an estimated $489K sold.

QRG Capital Management first reported a position in BNTX in Q3 2023 and held it in 7 quarters. The position peaked at $1.54M in Q1 2024. 284 funds tracked by Wall St. Rank hold BNTX as of Q4 2025.

  • QRG Capital Management reported no remaining BioNTech position as of Q4 2025 after selling out during the quarter.
  • QRG Capital Management sold 4,963 BioNTech shares in Q4 2025, an estimated $489K.
  • QRG Capital Management first reported a position in BioNTech in Q3 2023 and held it in 7 quarters.
  • QRG Capital Management's BioNTech position peaked at $1.54M in Q1 2024.
  • 284 funds tracked by Wall St. Rank held BioNTech as of Q4 2025.

Based on QRG Capital Management's 13F filing for Q4 2025, filed 2 Feb 2026.